Schizophrenia News and Research

Latest Schizophrenia News and Research

Rethinking therapy decisions in autoimmune encephalopathy

Researchers say that diagnosis and management of encephalopathies may need to be rethought, as many patients who test negative for the relevant antibody still benefit from immunotherapy.

4 Dec 2012

Vasculitis and the metabolic syndrome frequently co-exist

The metabolic syndrome is significantly more common in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis than healthy individuals, researchers have found.

3 Dec 2012

Reduced production of myelin may play role in development of mental illness: Study

Reduced production of myelin, a type of protective nerve fiber that is lost in diseases like multiple sclerosis, may also play a role in the development of mental illness, according to researchers at the Graduate School of Biomedical Sciences at Mount Sinai School of Medicine.

1 Dec 2012

Deficiencies in sensory information processing can explain complex symptoms of schizophrenia

Researchers at the University of California, San Diego School of Medicine and the VA San Diego Healthcare System have found that deficiencies in the neural processing of simple auditory tones can evolve into a cascade of dysfunctional information processing across wide swaths of the brain in patients with schizophrenia.

30 Nov 2012

Asthma and nasal congestion common insomnia triggers

Insomnia is a common problem in patients with asthma, suggests research published in Allergy.

30 Nov 2012

Tdap well tolerated in over-65s

Off-label use of tetanus–diptheria–acellular pertussis vaccine in senior patients results in no more adverse events than the tetanus and diphtheria vaccine, a US study shows.

30 Nov 2012

Poor empathy may feature in common psychiatric conditions

Individuals with schizophrenia, bipolar disorder, or depression may be less empathic than individuals without these conditions, according to German study results.

30 Nov 2012

Yale and Mainz University Medical Center to extend collaboration

The University Medical Center at Johannes Gutenberg University Mainz, Germany and the renowned School of Medicine at Yale University, USA have agreed upon a future collaboration. This strategic partnership promises to provide an innovative stimulus for the Research Unit Translational Neurosciences at the Mainz University Medical Center. The resulting regular exchange will benefit both basic research and the training of young researchers.

29 Nov 2012

Reduction in myelin production may also play a role in development of mental illness

29 Nov 2012

Polydipsia linked to brain alterations in schizophrenia

Psychogenic polydipsia is associated with significantly reduced left insula volume in patients with schizophrenia, researchers report.

28 Nov 2012

Watch out for Sjögren's syndrome in dry eye

Clinicians with patients who have clinically significant dry eye should be on the alert for underlying Sjögren's syndrome, report researchers in the British Journal of Ophthalmology.

28 Nov 2012

Off label atypical antipsychotic use lacks safety and effectiveness in patients over 40

In older adults, antipsychotic drugs are commonly prescribed off-label for a number of disorders outside of their Food and Drug Administration (FDA)-approved indications - schizophrenia and bipolar disorder. The largest number of antipsychotic prescriptions in older adults is for behavioral disturbances associated with dementia, some of which carry FDA warnings on prescription information for these drugs.

28 Nov 2012

University of Minnesota senior psychology fellow wins 2013 Grawemeyer Award

A mental health pioneer who explored the basis of schizophrenia and the way mental disorders are classified has won the 2013 University of Louisville Grawemeyer Award for Psychology.

28 Nov 2012

Trauma does not negatively impact cognition in schizophrenia

A history of trauma or post-traumatic stress disorder is not associated with poorer cognitive functioning in patients with schizophrenia, researchers report.

27 Nov 2012

XTL Biopharmaceuticals purchases 4,620,356 shares of Proteologics from Teva

XTL Biopharmaceuticals Ltd., a biopharmaceutical development company, announced on November 21st that it has acquired 4,620,356 shares, of Proteologics Ltd., from Teva Pharmaceutical Industries Ltd. in consideration for an amount of approximately NIS 6.5 million, which represents an amount of NIS 1.405 per Share (approximately 22% premium).

27 Nov 2012

Azathioprine exposure concerns raised for SLE mothers

Researchers have raised the possibility of an increased risk for developmental delay in the children of mothers who used azathioprine for systemic lupus erythematosus during pregnancy.

26 Nov 2012

Negative messages not having an impact in people with addictive behaviors

What types of public messages will most likely deter drug and alcohol abuse or dissuade people from engaging in risky behavior? Negatively framed messages may not be an effective way to reach those most in need of persuasion, suggests a new study in Psychology of Addictive Behaviors by researchers from Indiana University and Wayne State University.

26 Nov 2012